Literature DB >> 9551396

Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.

S E Thomas1, T F Andoh, R H Pichler, S J Shankland, W G Couser, W M Bennett, R J Johnson.   

Abstract

Recently we developed a model of cyclosporine nephropathy in rats characterized by tubulointerstitial (TI) injury, macrophage infiltration, and progressive interstitial fibrosis [1, 2]. To determine if the TI injury accompanying cyclosporine A (CsA) nephropathy was associated with accelerated apoptosis and ischemia, we treated rats for five weeks with CsA with or without losartan (to block angiotensin II type 1 receptor), or hydralazine/furosemide (H/F) (protocol #1). In protocol #2, rats received CsA with or without L-NAME (to block nitric oxide) or L-arginine (to provide a precursor to nitric oxide formation). Cyclosporine A treated rats had increased apoptosis of tubular and interstitial cells documented by PAS, propidium iodide staining, TUNEL assay, and electron microscopy compared to vehicle treated controls. Macrophages containing apoptotic cells could be confirmed by TUNEL/ED-1 doublestaining and colocalized in areas of TI injury. Animals treated with CsA + losartan had a statistically significant decrease in apoptosis (TUNEL + cells/mm2) when compared to CsA treated animals (6.0 vs. 19.9, P < or = 0.0001). The decrease in apoptosis in the CsA + H/F group was not statistically significant. Animals treated with CsA + L-NAME had a statistically significant increase in apoptosis compared to the CsA treated animals (12.3 vs. 6.4, P = 0.001). L-arginine administration with CsA resulted in a decrease in tubulointerstitial apoptosis versus CsA treated animals, however, this did not reach statistical significance. The addition of L-arginine did result in a significant reduction in interstitial fibrosis (P < 0.0001). Regression analysis revealed a significant correlation between apoptosis and interstitial fibrosis in both protocols. (CsA vs. CsA + losartan r = 0.63, P < 0.0001; CsA vs. CsA + L-NAME r = 0.83, P < 0.0001). We conclude that CsA nephropathy is associated with a marked increase in apoptosis of tubular and interstitial cells. Cyclosporine A induced apoptosis is partially mediated by angiotensin II and nitric oxide inhibition, suggesting a role for renal ischemia in this process, and CsA induced apoptosis correlates with interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551396     DOI: 10.1111/j.1523-1755.1998.00835.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.

Authors:  Michael M Yeboah; Md Abdul Hye Khan; Marla A Chesnik; Amit Sharma; Mahesh P Paudyal; John R Falck; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-29

2.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Authors:  Masashi Nishida; Hidehiko Fujinaka; Taiji Matsusaka; James Price; Valentina Kon; Agnes B Fogo; Jeffrey M Davidson; MacRae F Linton; Sergio Fazio; Toshio Homma; Hiroaki Yoshida; Iekuni Ichikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

4.  Reciprocal regulation of cyclic GMP content by cyclic GMP-phosphodiesterase and guanylate cyclase in SHR with CsA-induced nephrotoxicity.

Authors:  N Hosogai; J Seki; T Goto
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.

Authors:  A Fornoni; H Li; A Foschi; G E Striker; L J Striker
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

Authors:  Maarten Naesens; Evelyne Lerut; Hylke de Jonge; Boudewijn Van Damme; Yves Vanrenterghem; Dirk R J Kuypers
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

Review 7.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

9.  Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity.

Authors:  Beom Jin Lim; Pyung Kil Kim; Soon Won Hong; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

10.  Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats.

Authors:  Eun Young Lee; Mi Young Lee; Soon Won Hong; Choon Hee Chung; Sae Yong Hong
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.